Phase II trial of gemcitabine and cisplatin (GC) as neoadjuvant chemotherapy in unresectable stage III non-small cell lung cancer (NSCLC).

被引:0
|
作者
Crino, L
Mazzoni, F
Maestri, A
Calandri, C
Selvaggi, G
Scagliotti, GV
De Marinis, F
Gregorc, V
Darwish, S
Tonato, M
机构
[1] Bellaria Hosp, Bologna, Italy
[2] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
[3] Forlanini Hosp, Pneumol Div 3, Rome, Italy
[4] Monteluce Policlin, Perugia, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
489O
引用
收藏
页码:108 / 108
页数:1
相关论文
共 50 条
  • [1] Cisplatin and gemcitabine (GC) as neoadjuvant therapy of stage III unresectable non-small cell lung cancer (NSCLC):: A phase II study
    Mazzoni, F
    Di Stefano, A
    Maestri, A
    Calandri, C
    Mosconi, AM
    De Marinis, F
    Scagliotti, GV
    Selvaggi, G
    Crinò, L
    Tonato, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 8 - 8
  • [2] The combination of gemcitabine and cisplatin as neoadjuvant chemotherapy for early stage non-small cell lung carcinoma (NSCLC): An interim analysis of a phase II trial.
    Aydiner, A
    Kiyik, M
    Cikrikcioglu, S
    Kosar, F
    Gurses, A
    Turna, A
    Yazar, A
    Dilege, S
    Goksel, T
    Cakan, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 695S - 695S
  • [3] A phase II study of neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage III unresectable non-small cell lung cancer
    Iacobelli, S
    Irtelli, L
    Sacco, R
    Martino, M
    Mascitelli, E
    Basilico, L
    Scognamiglio, M
    Natoli, C
    Fusco, O
    Tinari, N
    Beltrami, V
    [J]. ANTICANCER RESEARCH, 1998, 18 (3B) : 2081 - 2084
  • [4] Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer
    Bunn, Paul A., Jr.
    Gaspar, Laurie E.
    Weyant, Michael J.
    Mitchell, John D.
    [J]. CANCER, 2016, 122 (05) : 674 - 675
  • [5] Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer
    Rinaldi, M
    Crinò, L
    [J]. LUNG CANCER, 2001, 34 : S25 - S30
  • [6] Neoadjuvant chemotherapy with navelbine (NVB) plus cisplatin (C) in stage IIIB in non-small cell lung cancer (NSCLC): A phase II trial
    Cigolari, S
    Curcio, C
    Massimo, M
    Sessa, R
    Vasta, M
    Maiorino, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1090 - 1090
  • [7] Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin in Stage IIIA/B Non-Small Cell Lung Cancer
    Maximiliano Van Kooten
    Moisés Rosenberg
    Mauro Orlando
    José Morero
    Manuel Vilanova
    Oscar Rojas
    Héctor Vicente
    Claudia Bagnes
    Carlos Silva
    Reinaldo D. Chacón
    [J]. Investigational New Drugs, 2002, 20 : 439 - 446
  • [8] Neoadjuvant chemotherapy with gemcitabine and cisplatin in stage IIIA/B non-small cell lung cancer
    Van Kooten, M
    Rosenberg, M
    Orlando, M
    Morero, J
    Vilanova, M
    Rojas, O
    Vicente, H
    Bagnes, C
    Silva, C
    Chacón, RD
    [J]. INVESTIGATIONAL NEW DRUGS, 2002, 20 (04) : 439 - 446
  • [9] Phase II trial with carboplatin/gemcitabine induction chemotherapy followed by radiotherapy concomitantly with paclitaxel/gemcitabine in stage III non-small cell lung cancer (NSCLC).
    Hirsh, V.
    Duclos, M.
    Souhami, L.
    Del Vecchio, P.
    Ofiara, L.
    Faria, S.
    Ayoub, J.
    Charpentier, D.
    Portelance, L.
    Soulieres, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 398S - 398S
  • [10] Sub-analyses of responders of a phase III trial of erlotinib combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Reck, Martin
    Klughammer, Barbara
    Montavon, Pierre
    Ward, Carol
    De Rosa, Flavio
    Brennscheidt, Ulrich
    Gatzemeier, Ulrich
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 169 - 170